Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning

Metformin is a first-line drug used for the treatment of type 2 diabetes. Recently, metformin has been reported to reduce the carcinogenic risk and inhibit tumor cell growth in glioma and breast cancer. The anticancer action of metformin involves the enhancement of phosphorylation of liver kinase B1...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncol Lett
Hoofdauteurs: IRIE, HARUKO, BANNO, KOUJI, YANOKURA, MEGUMI, IIDA, MIHO, ADACHI, MASATAKA, NAKAMURA, KANAKO, UMENE, KIYOKO, NOGAMI, YUYA, MASUDA, KENTA, KOBAYASHI, YUSUKE, TOMINAGA, EIICHIRO, AOKI, DAISUKE
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: D.A. Spandidos 2016
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734273/
https://ncbi.nlm.nih.gov/pubmed/26893732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4075
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items